Search

Tissue Modeling May Cut Clinical Trial Time

Obsidian Therapeutics Announces $49.5 Million Series A Financing to Develop Controllable Cell and Gene Therapy Products

Amgen Teams Up With Cambridge Biotech Community To Select Two Startups To Receive Golden Tickets At LabCentral

Affinivax $6.99 million Fundraising. Steven Brugger Released Jan 5 SEC form

Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs

LabCentral Gallery 1832 Features Large-Scale, Neo-Expressionist, Figurative Work by Boston-Area Artist, Sorin Bica

New England Biolabs Supports Creation of LabCentral Learning Lab

Read More

Agilent Awards Angiex with a Golden Ticket at LabCentral

Read More

Pioneer in Taking Immunotherapies Through the Clinic Joins Dragonfly Therapeutics as Chief Medical Officer

Elsevier Welcomes Six Biotech and Pharma Start-ups to The Hive, Supporting the Most Cutting-edge Research in Industry